Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement.
about
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusionLeucoreduction of blood components: an effective way to increase blood safety?Universal WBC reduction: the case for and against.Human Cytomegalovirus (HCMV) - Revised.Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study.Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.Transfusion and risk of infection in Canada.Transfusion and risk of infection in Canada: UPDATE 2004.Transfusion and risk of infection in Canada: Update 2005.Transfusion and risk of infection in Canada: Update 2006.Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy.Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.Continuous cytomegalovirus seroconversion in a large group of healthy blood donors.Prevention and Management of Postpartum Haemorrhage
P2860
Q24187243-EA24CFDE-2344-43AA-A0F4-24C2E9DFF226Q26771857-3B83AF4B-8205-489D-BF77-A43152A6AFB3Q34247853-8BC3935E-D5D8-49AE-9D9C-B085C977E885Q34625453-6DD69147-2349-4EB5-B7C5-2CAE5267ED16Q35350519-74CBF295-26E7-47EE-A416-F19A98E2C3EFQ35732096-CB61D401-59F4-4830-B787-9C4535C3539FQ36170689-AB7C2B11-8BB4-473F-B282-15FFDB0853CFQ36170838-B587B79F-D01E-4225-8434-A3F6A4EB317FQ36171013-63A1F299-AC36-4B6B-821B-81B7950C9A32Q36171185-F40EF2FF-2197-4A5B-BA04-CED3912B36CAQ36692135-E2980AAC-6CD6-436C-A994-3AC5F1845920Q36807473-4B0D9656-51CD-4A15-99EA-3BE27F572E1EQ37323823-411D976B-6398-490C-B1EE-8A870E212E0AQ37680941-6FA4B83D-36CB-402E-B58C-3DB1D8A95335Q39849819-DB8581EB-2840-491D-9148-9A6A6471AE7FQ46022341-9CB7E311-1AFE-4188-BB44-2F159B2742AAQ52003006-9754EAC1-CE76-4AEA-BA2A-0B6E756FD8C9Q56674877-DAB509B2-7729-4760-8CF2-93715763B8BA
P2860
Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prevention of posttransfusion ...... uction: a consensus statement.
@ast
Prevention of posttransfusion ...... uction: a consensus statement.
@en
Prevention of posttransfusion ...... uction: a consensus statement.
@nl
type
label
Prevention of posttransfusion ...... uction: a consensus statement.
@ast
Prevention of posttransfusion ...... uction: a consensus statement.
@en
Prevention of posttransfusion ...... uction: a consensus statement.
@nl
prefLabel
Prevention of posttransfusion ...... uction: a consensus statement.
@ast
Prevention of posttransfusion ...... uction: a consensus statement.
@en
Prevention of posttransfusion ...... uction: a consensus statement.
@nl
P2093
P2860
P1433
P1476
Prevention of posttransfusion ...... uction: a consensus statement.
@en
P2093
Costello B
Freedman J
Kleinman S
Laupacis A
Mazzulli T
P2860
P304
P356
10.1046/J.1537-2995.2001.41040560.X
P577
2001-04-01T00:00:00Z